Correlation Between Neurotech International and Challenger

Can any of the company-specific risk be diversified away by investing in both Neurotech International and Challenger at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurotech International and Challenger into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurotech International and Challenger, you can compare the effects of market volatilities on Neurotech International and Challenger and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurotech International with a short position of Challenger. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurotech International and Challenger.

Diversification Opportunities for Neurotech International and Challenger

-0.17

Correlation Coefficient

Neurotech International  Challenger

Good diversification

The 3 months correlation between Neurotech and Challenger is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Neurotech International and Challenger in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Challenger and Neurotech International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurotech International are associated (or correlated) with Challenger. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Challenger has no effect on the direction of Neurotech International i.e., Neurotech International and Challenger go up and down completely randomly.

Pair Corralation between Neurotech International and Challenger

Assuming the 90 days trading horizon Neurotech International is expected to under-perform the Challenger. In addition to that, Neurotech International is 2.84 times more volatile than Challenger. It trades about -0.08 of its total potential returns per unit of risk. Challenger is currently generating about -0.05 per unit of volatility. If you would invest  622.00  in Challenger on September 12, 2024 and sell it today you would lose (33.00) from holding Challenger or give up 5.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Neurotech International  vs.  Challenger

Neurotech International

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurotech International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Challenger

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Challenger has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Challenger is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Neurotech International and Challenger

The main advantage of trading using opposite Neurotech International and Challenger positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurotech International position performs unexpectedly, Challenger can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Challenger will offset losses from the drop in Challenger's long position.

The idea behind Neurotech International and Challenger pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.